AliveCor QT Service vs Assert-IQ
AI Verdict
Choose AliveCor QT Service if…
Choose AliveCor QT Service if you need instant, accurate QT and QTc interval measurements to assess cardiac safety, particularly when making medication prescribing decisions. This cloud-based SaMD is ideal for healthcare professionals utilizing AliveCor 6-Lead ECG devices who require rapid, on-demand QT analysis integrated into their clinical workflow.
View AliveCor QT Service →Choose Assert-IQ if…
Choose Assert-IQ if your patients require long-term, continuous cardiac monitoring for comprehensive arrhythmia detection over an extended period. This insertable cardiac monitor system is best suited for diagnosing and managing suspected heart rhythm disorders that may be intermittent and difficult to capture with shorter-term external monitoring solutions.
View Assert-IQ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AliveCor QT Service | Assert-IQ |
|---|---|---|
| Pricing | Varies by product and service, with subscription options available. | Enterprise |
| Deployment | Mobile app, cloud-based platform, EHR integration. | Hybrid |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | 1 AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AliveCor QT ServiceTool A, a cloud-based software service analyzing ECGs from an external, portable device, offers a more straightforward and less invasive usability for healthcare professionals in terms of immediate interaction and workflow for point-of-care QT screening. Tool B, while offering remote monitoring, requires a minimally invasive surgical procedure for insertion, which adds a significant initial barrier to usability for both patient and clinician.
Clinical Value
Assert-IQTool B offers a broader and potentially more impactful clinical value due to its long-term continuous monitoring (up to 6 years) and advanced arrhythmia detection capabilities. This is crucial for diagnosing elusive and intermittent heart rhythm disorders that might otherwise be missed, providing comprehensive diagnostic data for a wide range of arrhythmias.
Pricing & Value
TieBoth tools lack transparent public pricing for their professional services, requiring direct contact with the vendor for institutional or enterprise pricing. While some indicative costs for related consumer products (Tool A) or expired devices (Tool B) exist, a direct comparison of their pricing models and overall value for the specific services is not possible with the available information.
Enterprise Readiness
AliveCor QT ServiceTool A demonstrates superior enterprise readiness due to its explicit offering of an API for seamless integration with a wide range of existing healthcare IT systems, including EHR, CRM, EDC, and PSP platforms. In contrast, Tool B's stated lack of an API in the provided facts, despite targeting large health systems, presents a significant hurdle for comprehensive enterprise-wide data integration.
Innovation
Assert-IQTool B exhibits a higher degree of innovation, particularly with its world-leading 6-year battery life for an insertable cardiac monitor, combined with advanced AI algorithms for arrhythmia detection and remote programming capabilities. This pushes the boundaries of long-term, continuous, and intelligent cardiac diagnostics more significantly than Tool A's AI-driven analysis of a point-of-care ECG.
Support & Docs
Assert-IQBoth companies offer robust support channels and documentation. However, Tool B, given the nature of an implantable device, provides a more extensive and detailed suite of manuals and guides specifically tailored for clinicians and patients, covering device usage, programming, and remote monitoring, which is critical for such a complex medical device.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AliveCor QT Service | Assert-IQ |
|---|---|---|
| Name | AliveCor QT Service | Assert-IQ |
| Company | AliveCor | Abbott Medical |
| Description | A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. | The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. |
| Key Features | Cloud-based Software as a Medical Device (SaMD); Measures QT and QTc intervals (Bazett's and Fridericia's formulas); Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L); Prescription (Rx) use only, for qualified healthcare professionals; Utilizes AI and deep neural networks for ECG analysis; Provides instant QT measurements (as InstantQT); Integrates with KardiaStation app and KardiaPro portal; API available for integration with EHR, SDK, CRM, EDC, and PSP platforms | Long-term continuous cardiac monitoring (up to 6 years); Advanced arrhythmia detection algorithms; Bluetoothu00ae Low Energy data transmission; Secure cloud-based data platform; Remote monitoring capabilities; Proactive clinician alerts; Patient activator for symptom logging; Minimally invasive insertion |
| API Available | 1 | no |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring AliveCor QT Service and Assert-IQ.
Frequently Asked Questions
More Comparisons
More matchups featuring AliveCor QT Service or Assert-IQ
Backers
Who funded each tool's parent company.